openPR Logo
Press release

Streptococci Testing Market Opportunities and Forecast 2016 - 2024

04-14-2017 02:48 PM CET | IT, New Media & Software

Press release from: TMR - Research Reports

Streptococci Testing Market Opportunities and Forecast 2016 -

Streptococci Testing Market: Overview

Streptococcal infections are caused by a microorganism called Streptococcus which is a non-motile, microaerophilic, grampositive spherical bacterium. Several disease causing strains of the bacteria include streptococci (groups A, B, C, D, and G). Each group causes specific types of infections and symptoms. Group A strain of the bacteria are the most virulent species for humans and cause wound and skin infections, strep throat, scarlet fever, tonsillitis, blood infections (septicemia), pneumonia, Sydenham's chorea., rheumatic fever and glomerulonephritis.

Browse Complete Report Details of this Market at: http://www.transparencymarketresearch.com/streptococci-testing-market.html

Streptococci are known to originate from several natural sources, including humans and diverse animals. These bacteria often colonize on the mucosal surfaces of the mouth, nasal passages, intestinal tract, and pharynx. Moreover, the bacteria may also cause contamination of drinking water due to feces. Food products which are at high risk of contamination include milk and dairy products, steamed lobster, eggs, potato salad, ground ham, rice pudding custard, and shrimp salad. Some streptococci are commercially important for the production of cheese and yogurt, though are known to be potent pathogen.

The bacteria species which do not cause any infection and are used in food industry include S. lactis, S. diacelillactis S. cremoris, and S. thermophilus, the latter being the most well-known. The factors affecting the incidences of sore throats (pharyngitis) include seasonal variation, patient’s age, and geography. Pharyngitis most of the times is bacterial, though can be viral. Children ranging from 5 to 15 years of age are most susceptible to the infection by group A strep during the winter or early spring season. Symptoms of this infection include stomach aches, headaches, vomiting, nausea, and listlessness.

Streptococci Testing Market: Key Segments

The global streptococci testing market can be segmented based in tests type, end users and geography. Antibody tests include the antistreptolysin O titer (ASO), anti-DNase-B (ADB) test and Streptozyme. ASO test helps in determining a kidney disease glomerulonephritis, scarlet fever or rheumatic fever. ADB test is performed to determine a previous infection of a group A beta-hemolytic Streptococcus. Streptozyme is a screening test used to detect antibodies to several streptococcal antigens. Diagnostic tests include throat culture and rapid antigen test. Diagnostic tests are used to confirm the infection where in the sample from the infected area is used as culture, a means of growing bacteria artificially in the laboratory.

The cause of a sore throat is usually diagnosed on the basis of a physical exam and lab tests. A throat culture also known as strep test helps in detection of the presence of group A strain of streptococcal bacteria by using a throat swab. This strain is the most common cause of strep throat infection. Various other infections caused by these bacteria include pneumonia, meningitis and tonsillitis. Rapid antigen test can detect strep bacteria in minutes by looking for substances (antigens) in the throat. The rapid strep test detects the presence of a carbohydrate antigen which is unique to group A Streptococcus.

The downside to the rapid test is that it cannot detect the presence of Group C and G which can also cause streptococcal pharyngitis. On positive rapid strep test, the treatment is started with appropriate antibiotics to prevent long-term damage and recurrence. End users segment include hospitals, private labs, physicians offices and public health labs. Geographically, the global streptococci testing market is segmented into four major regions namely, North America, Europe, Asia-Pacific and Rest of the World.

Obtain the Sample PDF Research Report for this Market at: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=11516

Streptococci Testing Market: Key Players

The key players contributing to Streptococci market include Abbott Diagnostics, Beckman Coulter, bioMerieux, DiaSorin, Hologic, Qiagen, Roche Diagnostics, Novartis Diagnostics, Ortho Clinical Diagnostics, Sigma Aldrich, and Thermo Fischer Scientific.

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Streptococci Testing Market Opportunities and Forecast 2016 - 2024 here

News-ID: 502854 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Streptococci

Streptococci Testing Market Shares, Strategies and Forecast Worldwide, 2016 - 20 …
Streptococci Testing Market: Overview Streptococcal infections are caused by a microorganism called Streptococcus which is a non-motile, microaerophilic, grampositive spherical bacterium. Several disease causing strains of the bacteria include streptococci (groups A, B, C, D, and G). Each group causes specific types of infections and symptoms. Group A strain of the bacteria are the most virulent species for humans and cause wound and skin infections, strep throat, scarlet fever, tonsillitis, blood
Streptococci Testing Market: Trends, Business Strategies and Opportunities
Streptococcal infections are caused by a microorganism called Streptococcus which is a non-motile, microaerophilic, grampositive spherical bacterium. Several disease causing strains of the bacteria include streptococci (groups A, B, C, D, and G). Each group causes specific types of infections and symptoms. Group A strain of the bacteria are the most virulent species for humans and cause wound and skin infections, strep throat, scarlet fever, tonsillitis, blood infections (septicemia), pneumonia, Sydenham’s chorea., rheumatic fever
Streptococci Testing Market Research Report Shows Speedy Growth 2024
Streptococci are known to originate from several natural sources, including humans and diverse animals. These bacteria often colonize on the mucosal surfaces of the mouth, nasal passages, intestinal tract, and pharynx. Moreover, the bacteria may also cause contamination of drinking water due to feces. Food products which are at high risk of contamination include milk and dairy products, steamed lobster, eggs, potato salad, ground ham, rice pudding custard, and shrimp
Streptococci Testing Market - Overall Scope Of Industry Analysis & Forecast 2016 …
Streptococci Testing Market: Overview Streptococcal infections are caused by a microorganism called Streptococcus which is a non-motile, microaerophilic, grampositive spherical bacterium. Several disease causing strains of the bacteria include streptococci (groups A, B, C, D, and G). Each group causes specific types of infections and symptoms. Group A strain of the bacteria are the most virulent species for humans and cause wound and skin infections, strep throat, scarlet fever, tonsillitis, blood infections (septicemia), pneumonia, Sydenham's
Streptococci Testing Market Will Generate New Growth Opportunities by 2024
Streptococci Testing Market: Overview Streptococcal infections are caused by a microorganism called Streptococcus which is a non-motile, microaerophilic, grampositive spherical bacterium. Several disease causing strains of the bacteria include streptococci (groups A, B, C, D, and G). Each group causes specific types of infections and symptoms. Group A strain of the bacteria are the most virulent species for humans and cause wound and skin infections, strep throat, scarlet fever, tonsillitis, blood
Streptococci Testing Market Demand and Growth by 2024
Streptococci Testing Market: Overview Streptococcal infections are caused by a microorganism called Streptococcus which is a non-motile, microaerophilic, grampositive spherical bacterium. Several disease causing strains of the bacteria include streptococci (groups A, B, C, D, and G). Each group causes specific types of infections and symptoms. Group A strain of the bacteria are the most virulent species for humans and cause wound and skin infections, strep throat, scarlet fever, tonsillitis, blood